| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T137 |
0-194 |
Sentence |
denotes |
In the respiratory tract of primates, positive labeling for ACE2 has been reported at multiple sites, from the nasal and oral mucosa, to the larynx, trachea, bronchi and lung (Liu et al., 2011). |
| T138 |
195-480 |
Sentence |
denotes |
Whether ACE2 is expressed in human nasal and oral epithelium remains unclear, as contradictory results have been reported by studies using immunohistochemistry (Hamming et al., 2004; Bertram et al., 2012), in face of positive single-cell RNA sequencing findings (Sungnak et al., 2020). |
| T139 |
481-651 |
Sentence |
denotes |
This point is of great interest to understand the role of those tissues in SARS-CoV-2 initial infection, spread and clearance (section “Links Between ACE2 and COVID-19”). |
| T140 |
652-809 |
Sentence |
denotes |
In the upper respiratory tract ACE2 is expressed in the epithelial lining and lamina propria, in some muscle cells and in the salivary gland duct epithelium. |
| T141 |
810-1104 |
Sentence |
denotes |
In the lung, an intense signal for ACE2 protein has been consistently observed in type I and II pneumocytes in several species, including mouse, rat, cat, ferret, monkey and human (Wiener et al., 2007; van den Brand et al., 2008; Liu et al., 2011; Wong et al., 2012; Chen et al., 2013; Zhang B. |
| T142 |
1105-1122 |
Sentence |
denotes |
N. et al., 2019). |
| T143 |
1123-1287 |
Sentence |
denotes |
Data from rodents suggest an age- and gender-dependent pattern of expression, with a more rapid decline with age in males as compared to females (Xie et al., 2006). |
